Lv11
28 积分 2024-11-11 加入
The race to reset autoimmune diseases
5小时前
待确认
Sequential immunotherapy: towards cures for autoimmunity
5小时前
已完结
Informing the Recommended Phase III Dose of Alnuctamab, a CD3 × BCMA T‐Cell Engager, Using Population Pharmacokinetics and Exposure–Response Analysis
6天前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
6天前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
6天前
已完结
B-cell depletion in autoimmune diseases Georg Schett
8天前
已完结
B-cell depletion in autoimmune diseases
8天前
已关闭
Defining immune reset: achieving sustained remission in autoimmune diseases
16天前
已完结
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
28天前
已完结
NMOSD and MOGAD: an evolving disease spectrum
1个月前
已完结
皖公网安备34019202002308
